Neuroendocrine Tumours
Here below, you will find a list of all the latest content published on this website on the topic of Neuroendocrine Tumours. The content is published in chronological order. Find out more about our content categorisation .
-
« Previous
- 1
- 2
- ...
- 14
-
Next »
- ESMO E-Learning: Overview of Management of Well-Differentiated Pancreatic Neuroendocrine Tumours (PanNETs)
- ESMO Preceptorship on Gastroenteropancreatic Neuroendocrine Neoplasms Prague April 2019
- Summarising General Approach to GEP NENs Patients
- Chemotherapy and Molecular Targeted Agents Toxicity/Safety
- Participant Clinical Case Discussion: Treatment of a Patient with Metastatic DOTATATE-negative Neuroendocrine Neoplasia (G2) of the Ileum
- Endocrinological Toxicity
- PRRT Toxicity and Safety
- Participant Clinical Case Discussion: Metastatic Well-differentiated High-grade NET in the Pancreas
- Participant Clinical Case Discussion: Mixed (adenoneuroendocrine) Gastric Carcinoma
- High Grade GEP NENs Medical Treatments
- Mixed (Neuroendocrine + Non Neuroendocrine) GEP Neoplasms
- Somatostatin Analogs
- Genetic Syndromes: Clinical features
- Radiological Tumour Response Assessment
- How to Integrate Morphological and Functional Imaging - Nuclear Physician
- How to Integrate Morphological and Functional Imaging - Radiologist
- Other Clinical Syndromes
- Participant Clinical Case Discussion: Carcinoid Syndrome of Unknown Origin
- Carcinoid Syndrome
- Bases for Peptide Receptor Radionuclide Therapy (PRRT) in GEP NETs
- Locally Advanced Pancreatic NET Management
- Participant Clinical Case Discussion: The Value of Everolimus as Second-line Treatment in Pancreatic NEN
- Molecular Targeted Agents in GEP NETs
- Participant Clinical Case Discussion: Is There a Place For Re-challenge of PRRT in Neuroendocrine Tumors?
- Medical Oncologist (Metastatic Disease)
-
« Previous
- 1
- 2
- ...
- 14
-
Next »